Reflecting this, SOX9 expression was more frequently detected in metastatic HCC lesions of patients with both SOX9+ and SOX9− primary HCCs; about 90% in the metastatic regions and 30% in the primary HCCs. This evidence concerns the gene SOX9 and hepatocellular carcinoma.